7.50
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-05-25 | 2025-02-23 | 2024-11-24 | 2024-08-25 | 2024-05-26 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
3.67%
36.44
|
35.15 | 32.56 | 24.70 | 37.89 |
Cost Of Revenue |
11.25%
22.46
|
25.31 | 21.48 | 19.32 | 20.61 |
Gross Profit |
42.02%
13.98
|
9.845 | 11.08 | 5.387 | 17.27 |
|
54.14%
8.655
|
18.87 | 13.04 | 16.97 | 15.12 |
Benefits Costs and Expenses |
24.78%
37.56
|
49.93 | 39.09 | 40.96 | 45.03 |
Costs And Expenses |
24.78%
37.56
|
49.93 | 39.09 | 40.96 | 45.03 |
Operating Income/Loss |
159.00%
5.327
|
-9.029 | -1.959 | -11.58 | 2.149 |
Income/Loss From Continuing Operations Before Tax |
92.46%
-1.114
|
-14.78 | -6.528 | -16.25 | -7.143 |
Income Tax Expense/Benefit |
512.50%
0.033
|
-0.008 | 0.043 | -0.025 | -0.057 |
Income/Loss From Continuing Operations After Tax |
92.23%
-1.147
|
-14.77 | -6.571 | -16.23 | -7.086 |
Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | - | - | 0.003 |
|
92.23%
-1.147
|
-14.77 | -6.571 | -16.23 | -7.083 |
Preferred Stock Dividends And Other Adjustments |
65.52%
0.90
|
2.61 | 2.132 | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
98.00%
0.7388
|
37.02 | 34.36 | 30.86 | 0.024 |
Diluted Average Shares |
98.00%
0.7388
|
37.02 | 34.36 | 30.86 | 0.189 |
Basic Earnings Per Share |
93.62%
-0.03
|
-0.47 | -0.25 | -0.53 | -0.23 |
Diluted Earnings Per Share |
93.62%
-0.03
|
-0.47 | -0.25 | -0.53 | -0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
65.52%
0.90
|
2.61 | 2.132 | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):